Literature DB >> 23663980

Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity.

Misako Matsumoto1, Kenji Funami, Hiroyuki Oshiumi, Tsukasa Seya.   

Abstract

The innate immune system senses microbial infections using pattern-recognition receptors and signals to activate adaptive immunity. Type I transmembrane protein Toll-like receptors (TLRs) play important roles in antimicrobial immune responses. Upon the recognition of pathogen-associated molecular patterns, TLRs homo- or heterodimerize and recruit distinct adaptor molecules to the intracellular TIR domains. Toll-IL-1-receptor-containing adaptor molecule-1 (TICAM-1) is a signaling adaptor downstream of TLRs 3 and 4 that recognizes virus-derived double-stranded RNA and lipopolysaccharide, respectively. TLR3 is expressed on the endosomal membrane in myeloid DCs, where TLR3-mediated signaling is initiated. Once TICAM-1 is activated, transcription factors, IRF-3, NF-κB, and AP-1, are activated, leading to production of IFN-β and proinflammatory cytokines and maturation of dendritic cells, which are capable of activating NK cells and cytotoxic T cells. Hence, TICAM-1 signaling appears to link innate immunity to adaptive immunity. In this review, we summarize the current knowledge on TICAM-1 and discuss its role in virus infection and antitumor immunity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23663980     DOI: 10.1016/B978-0-12-386931-9.00018-0

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  7 in total

1.  NF-κB and IRF pathways: cross-regulation on target genes promoter level.

Authors:  Marta Iwanaszko; Marek Kimmel
Journal:  BMC Genomics       Date:  2015-04-17       Impact factor: 3.969

2.  Heterologous Expression and Assembly of Human TLR Signaling Components in Saccharomyces cerevisiae.

Authors:  Julia María Coronas-Serna; Elba Del Val; Jonathan C Kagan; María Molina; Víctor J Cid
Journal:  Biomolecules       Date:  2021-11-22

3.  Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients.

Authors:  Zhiyi Lu; Fengyin Sun
Journal:  BMC Med Genomics       Date:  2022-08-06       Impact factor: 3.622

4.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

Review 5.  Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Kumar Jayant; Nagy Habib; Kai W Huang; Jane Warwick; Ramesh Arasaradnam
Journal:  Diagnostics (Basel)       Date:  2020-05-25

Review 6.  Host Components That Modulate the Disease Caused by hMPV.

Authors:  Nicolás M S Gálvez; Catalina A Andrade; Gaspar A Pacheco; Jorge A Soto; Vicente Stranger; Thomas Rivera; Abel E Vásquez; Alexis M Kalergis
Journal:  Viruses       Date:  2021-03-22       Impact factor: 5.048

Review 7.  Activation of Innate Immunity by Therapeutic Nucleic Acids.

Authors:  Ali Bishani; Elena L Chernolovskaya
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.